文摘
摘要目的:我们的目标是确定疗效和安全性的救援支架在一群患者血栓切除术后急性基底动脉闭塞
背景:最近的随机对照试验证明机械血栓切除术的临床效益对急性基底动脉闭塞。大约10%的患者接受机械血栓切除术需要救援由于潜在残余狭窄血管成形术和支架植入主要成功的再灌注
设计/方法:pc搜索业务是一个全国范围的回顾注册表连续急性保治疗血栓切除术与来自八大容量中心在美国从2015年7月- 2021年12月。病人被包含在这个注册表,如果他们收到机械血栓切除术或动脉内的溶栓在24小时内的最后一次看到。良好的临床结果≤3夫人被定义为3个月。多元逻辑回归模型来确定预测病人良好的临床结果的救援支架。
结果:共有336名患者被纳入分析,其中50两个(6.5%)接受救援支架。没有年龄差异,承认署或电脑方面得分之间的支架和非支架组。良好的血管再通(≥TICI 2 b)是实现non-stent组的82% vs 91%支架组,P = 0.103。百分之四十五的患者达到≤3夫人与总死亡率的41.4%,90天non-stent组支架vs 44.2%组。相似率两组之间的西奇一被发现在救援支架(0% vs . 5.4)只在太组,p值0.089)。多变量分析表明类似的好的结果(可信区间0.53 - 1.964或1.26;p = 0.95)的救援支架相比,非支架组。
结论:急性患者基底动脉闭塞,救援支架由于潜在的残余狭窄,支架具有类似的并发症率似乎是安全的和有利的结果相比,没有支架组。
披露:Afreen博士没有披露。Mierzwa博士没有披露。扎伊迪博士没有披露。Aladamat博士没有披露。Gharaibeh博士没有披露。纳尔逊博士没有披露。奥尔特加古铁雷斯博士已经收到个人薪酬在10000 - 49999美元的范围为stryker担任顾问。奥尔特加古铁雷斯博士已经收到个人薪酬在10000 - 49999美元的范围为美敦力公司担任顾问。奥尔特加古铁雷斯博士已经收到个人薪酬在5000 - 9999美元的范围为microvention担任顾问。奥尔特加古铁雷斯博士已经收到个人补偿的范围0 - 499美元作为军官或SVIN董事会的成员。 The institution of Dr. Ortega Gutierrez has received research support from stryker. The institution of Dr. Ortega Gutierrez has received research support from Siemens. The institution of Dr. Ortega Gutierrez has received research support from IschemiaView. The institution of Dr. Ortega Gutierrez has received research support from Medtronic. Dr. Farooqui has nothing to disclose. Mr. Vivanco-Suarez has nothing to disclose. Dr. Jadhav has nothing to disclose. Dr. Desai has nothing to disclose. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dynamed. Dr. Toth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Microvention. Dr. Toth has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Alrohimi has nothing to disclose. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vesalio. Dr. Nguyen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avania. Dr. Nguyen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AHA. The institution of Dr. Nguyen has received research support from Boston Medical Center. The institution of Dr. Nguyen has received research support from Society of Vascular and Interventional Neurology. Mr. Klein has nothing to disclose. Mohamad Abdalkader has nothing to disclose. Dr. Pandey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NIH and SVIN- Journal. Dr. Pandey has stock in FlexDex. Dr. Pandey has stock in NextGen. The institution of Dr. Pandey has received research support from NIH. The institution of Dr. Pandey has received research support from Focused ultrasound foundation. Dr. Pandey has received intellectual property interests from a discovery or technology relating to health care. Sravanthi Koduri has nothing to disclose. Vora Shivangi has nothing to disclose. Nirav Vora has nothing to disclose. Dr. Jumaa has nothing to disclose. Sami Al Kasab has nothing to disclose.
